Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L., Stewart, W.F., AMPP Advisory Group. (2007, January 30). Migraine prevalence, disease burden, and the need for preventive therapy. Retrieved October 1, 2017 from, http://www.neurology.org/content/68/5/343.long
Raddant, A. C., & Russo, A. F. (2011, November 29). Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. National Institute of Health 13:36. Retrieved April 17, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/22123247
Bigal, M. E., & Lipton, R. B. (2008, September 09). Clinical course in migraine: conceptualizing migraine transformation. Neurology 71:11 848-855. Retrieved April 17, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/18779513
Bigal, M. E., & Lipton, R. B. (2009, August). Overuse of acute migraine medications and migraine chronification. Current Pain & Headache Reports, 13:301-307. Retrieved April 13, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/19586594
D'Amico, D., & Tepper, S. J. (2008, December). Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatric Disease and Treatment, 2008 Dec;4(6):1155-67. Retrieved April 13, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/19337456
Vos, Theo, et al. "Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 310 Diseases and Injuries, 1990-2015: a Systematic Analysis for the Global Burden of Disease Study 2015." The Lancet, vol. 388, no. 10053, 2016, pp. 1545-1602., doi:10.1016/s0140-6736(16)31678-6.
Messali, A., Sanderson, J.C., Blumenfeld, A.M., Goadsby, P.J., Buse, D.C., Varon, S.,F., Stokes, M., Lipton, R.B. (2016, February). Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey. Retrieved October 1, 2017 from, https://www.ncbi.nlm.nih.gov/pubmed/26833083
Lipton, R., Bigal, M., Kolodner, K., Stewart, W., Liberman, J., & Steiner, T. (2003, June 13). The family impact of migraine: populationâ€based studies in the USA and UK. Cephalalgia, 2003. 23(6): p. 429-40. Retrieved April 17, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/12807522
Dodick, David W., et al. "OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Doubleâ€Blind, Randomized, Placeboâ€Controlled Phases of the PREEMPT Clinical Program." Headache: The Journal of Head and Face Pain, Blackwell Publishing Inc, 7 May 2010, onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2010.01678.x/full.